RelB is a potential molecular biomarker for immunotherapy in human pan-cancer

Overview of attention for article published in Frontiers in Molecular Biosciences, June 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Anomaly Detection and Artificial Intelligence Identified the Pathogenic Role of Apoptosis and RELB Proto-Oncogene, NF-kB Subunit in Diffuse Large B-Cell Lymphoma

Article in BioMedInformatics (June 2024)

mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses

Article in BMC Cancer (May 2024)

Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis

Article in Cancer Letters (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.